VAERS Explorer
Back to explore

Report #2852352

Received Aug 1, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
Jun 6, 2025
Onset
Jun 8, 2025
Days to onset
2
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Rash

Symptom narrative

painful rash not at the injection site; This non-serious case was reported by a consumer and described the occurrence of painful rash in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 06-JUN-2025, the patient received Shingrix. On 08-JUN-2025, 2 days after receiving Shingrix, the patient experienced painful rash (Verbatim: painful rash not at the injection site). On 13-JUN-2025, the outcome of the painful rash was resolved (duration 5 days). It was unknown if the reporter considered the painful rash to be related to Shingrix. It was unknown if the company considered the painful rash to be related to Shingrix. Additional Information: GSK receipt date: 23-JUL-2025 Patient reported that she had painful rash not at the injection site.